Surgical Management of Pancreatic Neuroendocrine Tumors

Hematol Oncol Clin North Am. 2016 Feb;30(1):103-18. doi: 10.1016/j.hoc.2015.09.004. Epub 2015 Oct 24.

Abstract

Pancreatic neuroendocrine tumors (PNETs) are uncommon tumors with a range of clinical behavior. Some PNETs are associated with symptoms of hormone secretion, with increased systemic levels of insulin, gastrin, glucagon, or other hormones. More commonly, PNETs are nonfunctional, without hormone secretion. Surgical resection is the mainstay of therapy, particularly for localized disease. Surgical therapy must be tailored to tumor and clinical characteristics. Resection may be particularly indicated in the setting of hormone hypersecretion. Small, incidental PNETs are increasingly managed nonoperatively. Surgery may also be indicated in some instances of metastatic disease, if all metastatic foci may be removed.

Keywords: Enucleation; Neuroendocrine; Pancreas; Pancreatectomy; Surgery.

Publication types

  • Review

MeSH terms

  • Diagnostic Imaging / methods
  • Hormones / metabolism*
  • Humans
  • Neuroendocrine Tumors / diagnosis
  • Neuroendocrine Tumors / metabolism
  • Neuroendocrine Tumors / surgery*
  • Pancreas / metabolism
  • Pancreas / pathology
  • Pancreas / surgery*
  • Pancreatectomy / methods
  • Pancreatic Neoplasms / diagnosis
  • Pancreatic Neoplasms / metabolism
  • Pancreatic Neoplasms / surgery*
  • Practice Guidelines as Topic
  • Prognosis
  • Survival Analysis

Substances

  • Hormones